Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

74501-86-3Tobramycin Impurity 1

● Under Development

Catalogue No.:	VE009618
CAS No.:	74501-86-3
Mol. Formula:	C18H35N5O8
Mol. Weight:	449.5 g/mol

How can we help?

Add to RFQ list

Additional information on CAS 74501-86-3

Parent drug

Tobramycin

IUPAC Name

(2S, 3R, 4S, 5S, 6R)-4-amino-2-(((1S, 2S, 3R, 4S, 6R)-4, 6-diamino-3-(((2S, 3R)-3-amino-6-(aminomethyl)-3, 4-dihydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3, 5-diol

Synonyms

N/A

Description

It is an impurity of Tobramycin, it is an aminoglycoside antibiotic, tobramycin is used to treat eye infections, and cystic fibrosis-associated bacterial, it is a ring-containing aminoglycoside antibiotic and tobramycin against various Gram-negative and some Gram-positive bacteria.

References

Vazquez Espinosa, E., Giron Moreno, R. M., Gomez Punter, R. M., Garcia Castillo, E., Valenzuela, C., Cisneros Serrano, C., … Ancochea Bermudez, J. (2015). Long-term safety and efficacy of tobramycin in the management of cystic fibrosis. Therapeutics and Clinical Risk Management, 407. https://doi.org/10.2147/tcrm.s75208